NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S.

TORONTO, August 25, 2010 – Dalradian Resources Inc. (“Dalradian” or the “Company”) (TSX: DNA) (TSX: DNA.WT) announces that the agents in connection with its initial public offering that closed on August 10, 2010 (the “Offering”) have exercised the over-allotment option (the “Over-Allotment Option”) in part. As a result, the Company has issued 3,400,000 additional units (the “Additional Units”) for aggregate gross proceeds of C$5,100,000. Each Additional Unit consists of one common share (a “Common Share”) of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each Warrant entitles the holder to acquire one common share of the Company at an exercise price of C$2.25 until August 10, 2011.

On the closing of the Offering a total of 22,700,000 units of the Company were issued for aggregate gross proceeds of C$34,050,000. Following the closing of the Over-Allotment Option for 3,400,000 Additional Units, the Company has a total of 68,255,750 Common Shares issued and outstanding.

GMP Securities L.P. and Dundee Securities Corporation co-led the syndicate, which included Clarus Securities Inc. and Cormark Securities Inc.

The offer and sale of the securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an exemption from the registration requirements of the U.S. Securities Act. This news release does not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States.

For further information, please contact:
Annemarie Brissenden Director, Investor and Corporate Relations
Telephone: 416.572.2299
Email: investor@dalradian.com

- 30 -